Natera

Register for our oral presentation at #GI21 to hear about the largest #ctDNA study in early-stage CRC, showing Signatera's ability to detect recurrence early - a median of 8 months before clinical relapse! Learn more: http://ow.ly/ywhk50D7PLu #CRCSM #Oncology

You won't want to miss this! This Thursday, get to know patient advocates Melinda and Rachelle McCray - Melinda is an #AlportSyndrome patient and the recipient of a living #kidneytransplant, and now awaits her second kidney transplant. She is the mother of Rachelle McCray, a Nationally recognized TV host, entrepreneur, and former Miss Arizona United States and NFL cheerleader. Inspired by her mother's need for a kidney donor for a second transplant, Rachelle became a #patient...advocate and founded MinMinBear Foundation, whose mission is to help those affected by chronic illnesses like #kidneydisease. Hear more about the mother-daughter duo and how they're navigating the #pandemic during our fireside chat with our CMO Paul Billings at #ASTSWinter! Register here: https://www.natera.com/organ-health/asts-2021

A new multicenter, prospective study sheds new light on MRD detection using Signatera in stage II-III #colorectalcancer patients. Don't miss our oral presentation at #GI21 to hear about exciting new data being presented: http://ow.ly/t7F550D6T6V #CRCSM #SignateraLooksDeeper

[LIVE Event] For anyone looking to learn more about Natera’s journey and what lies ahead for the company, we highly recommend joining our CEO Steve Chapman and CFO Mike Brophy today at 3:40 pm ET at #JPM2021’s virtual healthcare conference! They’ll uncover where #Natera’s been and where we’re going. Follow this link to tune in to our session: https://jpmorgan.metameetings.net//s/35225-natera/webcast... #Biotechnology #CellFreeDNA

See Dr. Kotzker’s and Dr. Turgeon’s teams of fellows go head-to-head Family Feud style, answering questions about genetic kidney conditions and kidney allograft rejection! Friday, Nov. 6, 12 PM EDT / 9 AM PST. To register, go to http://ow.ly/6owR50C1aUv

We’re thrilled to announce brand new #data on #Signatera’s clinical performance in #ColorectalCancer, featuring the largest #ctDNA study in early-stage colorectal cancer! Through this study, we are able to demonstrate that serial ctDNA testing can detect molecular residual disease a median of eight months ahead of clinical relapse, with significant potential to improve patient care, said Claus Lindbjerg Andersen, Ph.D., Professor, Department of Molecular Medicine at Aarhus ...University. For a deeper look at the numbers, join us later this week at American Society of Clinical Oncology’s #GI21 symposium: https://www.natera.com//natera-present-new-colorectal-canc #Oncology #SignateraLooksDeeper

Transplant Nephrologist Prince Mohan, MD shares how Prospera is the cfDNA test that gives him the most information when assessing his transplant patients during surveillance. To learn more about real-world use cases, visit: https://www.natera.com/why-prospera#surveillance

How is Signatera improving clinical trials in Breast Cancer? What could this mean for patients? To find out and ask questions - register here: https://bit.ly/3n7UbjR for the Oct 27 Webinar with FiercePharma #BreastCancerAwarenessMonth #ctDNA #Signatera #ClinicalTrialDesign #BreastCancer #cfDNA

Natera is proud to be a member of the American Society of Transplantation (AST) Living Donor Circle of Excellence program. Recently launched, this program aims to eliminate the financial costs of living organ donation by recognizing companies whose policies support living donation. You can learn more about the program here: myAST.org/COE #livingdonorcircle

Join the #GLFTrickShot Challenge! Share your unique trick shot on social media and be sure to make a donation to help kidney patients in need during these difficult times: https://glftrickshotnatera.com/ #KidneyHealth #KidneyDisease

It's here! We've teamed up with Paltown Development Foundation to launch Colontown University, an online learning center for over 5,300 #colorectalcancer patients and caregivers. Natera will provide educational resources for our Signatera MRD test. Learn more: https://paltown.org/CTU-launch/

We’ve teamed up with the George Lopez Foundation to create the #GLFTrickShot Challenge to help kidney patients in need and raise awareness about #kidneydisease. Post your unique trick shot videos on social media with hashtags #GLFTrickShot and #KidneyHealth, link to our campaign page glftrickshotnatera.com, challenge your friends, and make a donation!

The GIFT Program offers complimentary, comprehensive educational opportunities focused on genetic testing and technology relevant to the #nephrology fellows community. Email [email protected] to enroll your fellowship program and hear about it at the #AST Fellows Symposium!

We're helping #nephrology fellows harness the power and potential of DNA when managing complex issues in renal health. Hear about it at the AST Fellows Symposium or email [email protected] for more info!

Learn about our Genetics in Fellowship Training (GIFT) Program at the #AST Fellows Symposium from September 24 -25th! Reach out to [email protected] to enroll your fellowship program in GIFT.

We’re excited to be presenting new Signatera data at #ESMO20, featuring 1 oral and 3 poster presentations showing the effectiveness of Signatera in stage IV oligometastatic #colorectalcancer (CRC), stage I-III CRC, and esophageal adenocarcinomas. Read our press release here: https://www.natera.com//natera-present-new-gastrointestina #SignateraLooksDeeper #ctDNA #ESMO

Signatera is now covered by Medicare in stages II-III colorectal cancer! Huge win for cancer patients and providers - expanding access to this new technology will help guide cancer care: http://ow.ly/si6k50BhBoB #medicarecoverage #colorectalcancer #SignateraLooksDeeper

More than sixty-five years after the first kidney transplant was performed in 1954, much has changed in the field of organ transplantation. Join four-time kidney transplant recipient and host of the podcast Kidney Talk, Lori Hartwell, as she talks to Natera’s Medical Director, Dr. Phil Gauthier, about recent innovations in the field and what recipients can do to both assess their new kidney’s health and ensure it stays healthy for as long as possible: http://ow.ly/2J0d50Bh8Af Renal Support Network